ISCC-PEG Pharmacogenomics Learning Series
The NHGRI Inter-Society Coordinating Committee for Practitioner Education in Genomics (ISCC-PEG) aims to improve genomic literacy of healthcare professionals and enhance the effective practice of clinical genomic medicine by facilitating interactions among the key stakeholders in genomics education.
The Pharmacogenomics (PGx) Project Group has developed the pharmacogenomics educational modules that be taken free of charge.
Pharmacogenomics Nomenclature
This module educates healthcare professionals about pharmacogenomics nomenclature and how to apply pharmacogenomics information into clinical decision making.
Enroll
Pharmacogenomics Resources
This module educates healthcare professionals about evidence-based pharmacogenomic
resources from the Food & Drug Administration (FDA), the Clinical Pharmacogenetics
Implementation Consortium (CPIC), and the Pharmacogenomics Knowledgebase (PharmGKB).
Practical Aspects of Pharmacogenomics Implementation
This module educates healthcare professionals about what elements are involved in implementing a simple population-focused, pharmacogenomic program.
Direct-to-Consumer Pharmacogenomic Testing
This module educates healthcare professionals towards a better understanding of the benefits and limitations of direct-to-consumer pharmacogenomic testing, when to pursue confirmatory clinical testing, and how to interpret pharmacogenomic test results using evidence-based resources.
Economics of Pharmacogenomic Testing
This module provides a case study to demonstrate treatment regimen decisions through cost-benefit analysis based on genetic testing, individual patient medical information, and risk factors.
Navigating PGx Test Coverage in Medicare Populations
This module explores key components of Medicare payer coverage guidance for pharmacogenomics testing including technical and documentation requirements.
Genetic Testing
This module educates healthcare professionals about core concepts in pharmacogenomic testing including the differences between genotyping and sequencing, limitations of testing, and the regulatory landscape. Important factors are included to guide clinicians through selecting a testing laboratory, informed consent, and interpretation of test results.
Genotype-Guided Clopidogrel Treatment
This module educates healthcare professionals about the impact of pharmacogenomic variability on clopidogrel effectiveness through a review of guidelines and case-based activities.
Optimization of Psychiatric Treatment with Pharmacogenomics
This module describes common genes associated with the effectiveness and safety of psychiatric medications as well as the impact of drug-drug interactions (phenoconversion) through case-based activities.